You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 13, 2024

DOXAPRAM HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Doxapram Hydrochloride, and what generic alternatives are available?

Doxapram Hydrochloride is a drug marketed by Chartwell Injectable and Watson Labs and is included in two NDAs.

The generic ingredient in DOXAPRAM HYDROCHLORIDE is doxapram hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the doxapram hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Doxapram Hydrochloride

A generic version of DOXAPRAM HYDROCHLORIDE was approved as doxapram hydrochloride by CHARTWELL INJECTABLE on January 10th, 2003.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DOXAPRAM HYDROCHLORIDE?
  • What are the global sales for DOXAPRAM HYDROCHLORIDE?
  • What is Average Wholesale Price for DOXAPRAM HYDROCHLORIDE?
Summary for DOXAPRAM HYDROCHLORIDE
US Patents:0
Applicants:2
NDAs:2
Raw Ingredient (Bulk) Api Vendors: 53
Clinical Trials: 14
Patent Applications: 199
What excipients (inactive ingredients) are in DOXAPRAM HYDROCHLORIDE?DOXAPRAM HYDROCHLORIDE excipients list
DailyMed Link:DOXAPRAM HYDROCHLORIDE at DailyMed
Drug patent expirations by year for DOXAPRAM HYDROCHLORIDE
Recent Clinical Trials for DOXAPRAM HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rehman Medical Institute - RMIPhase 4
Erasmus Medical CenterPhase 3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Phase 3

See all DOXAPRAM HYDROCHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for DOXAPRAM HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for DOXAPRAM HYDROCHLORIDE

US Patents and Regulatory Information for DOXAPRAM HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Injectable DOXAPRAM HYDROCHLORIDE doxapram hydrochloride INJECTABLE;INJECTION 076266-001 Jan 10, 2003 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs DOXAPRAM HYDROCHLORIDE doxapram hydrochloride INJECTABLE;INJECTION 073529-001 Jan 30, 1992 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.